Currently out of the existing stock ratings of Andrew Mok, 12 are a SELL (19.05%), 20 are a HOLD (31.75%), 31 are a BUY (49.21%).

Andrew Mok

Work Performance Price Targets & Ratings Chart

Analyst Andrew Mok works at BARCLAYS with a stock forecast success ratio of 53.61% fulfilled within 169.21 days on average. Previously, Andrew Mok worked at UBS.

Andrew Mok’s has documented 133 price targets and ratings displayed on 14 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on EHC, Encompass Health Corp at 28-Mar-2024.

Wall Street Analyst Andrew Mok

Analyst best performing recommendations are on AMED (AMEDISYS).
The best stock recommendation documented was for AMED (AMEDISYS) at 11/1/2022. The price target of $88 was fulfilled within 2 days with a profit of $7.12 (7.49%) receiving and performance score of 37.43.

Average potential price target upside

of $52.21 (21.59%) on HCA (HCA HOLDINGS).
of $26.02 (40.72%) on THC (TENET HEALTHCARE).
of $22.4 (27.27%) on DVA (DAVITA HEALTHCARE PARTNERS).

AMED Amedisys CYH Community Health Systems THC Tenet Healthcare UHS Universal Health Services EHC Encompass Health Corp HCA HCA Holdings ACHC Acadia Healthcare Company LHCG LHC Group OSH Oak Street Health DVA DaVita HealthCare Partners CANO Cano Health CMAX CareMax EHAB Enhabit . PRVA Privia Health Group

Show more stocks

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

John Ransom (RAYMOND JAMES)